ARCHIVES

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

This article is from The Cancer Letter archive.

Vol. 22 No. 47 | December 6, 1996

Download PDF Visit The Full Archive

Related Articles

Armstrong Foundation To Fund Studies In Testicular Cancer

April 17, 1998

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

Implants Don’t Cause Cancer, Long-Term Study Finds

May 26, 2006

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005